Close Menu
Home » 23andMe Sues Ancestry for Patent Infringement, Misleading Marketing

23andMe Sues Ancestry for Patent Infringement, Misleading Marketing

May 14, 2018
|
staff reporter

NEW YORK (GenomeWeb) – 23andMe sued rival Ancestry.com on Friday in a California federal district court, alleging infringement of its patented method of identifying relatives in a database and of false advertising. The company also asked the court to nullify the trademarked "ancestry" logotype.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Hahn Hearing

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

RNAi Drug for Acute Hepatic Porphyria

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Decade of DTC

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

Nature Studies Examine Native RNA Sequencing, Nanopore Sequencing Approach to Analyze STR Expansions

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.

What's Popular?

In Business News

  1. Illumina Expands IP Offer to Help Save PacBio Deal as Oxford Nanopore Cries Foul

  2. GenapSys Raises $90M in Series C Round, Launches Sequencer in US

  3. Private Equity Firms Cinven, Astorg to Acquire LGC

  4. Cancer Diagnostics Firm Lucence Raises $20M

  5. Qiagen Says It Is Fielding Acquisition Offers

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.